Contents Ingredients: Bulking Agent (Gum Arabic), S-Acetylglutathione, Capsule Shell (Hydroxypropyl Methylcellulose)
Lancet 359:20722077 Garvey WT, Ryan DH, Henry R et al (2014) Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release
They are not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease
The Clinical Evidence Supporting Weekly Semaglutide Dosing The STEP 1, STEP 2, STEP 3, and STEP 4 trialsthe largest clinical programs testing semaglutide for weight lossall utilized once-weekly dosing and demonstrated an average weight loss of 1015% of body weight over 68 weeks
If you need to discuss side effects, treatment progress, or dosage adjustments, you can consult with a clinician via our secure patient portal at no extra charge
Learn more about our medical team